Literature DB >> 11316804

c-Jun binds the N terminus of human TAF(II)250 to derepress RNA polymerase II transcription in vitro.

T N Lively1, H A Ferguson, S K Galasinski, A G Seto, J A Goodrich.   

Abstract

c-Jun is an oncoprotein that activates transcription of many genes involved in cell growth and proliferation. We studied the mechanism of transcriptional activation by human c-Jun in a human RNA polymerase II transcription system composed of highly purified recombinant and native transcription factors. Transcriptional activation by c-Jun depends on the TATA-binding protein (TBP)-associated factor (TAF) subunits of transcription factor IID (TFIID). Protein-protein interaction assays revealed that c-Jun binds with high specificity to the largest subunit of human TFIID, TAF(II)250. The region of TAF(II)250 bound by c-Jun lies in the N-terminal 163 amino acids. This same region of TAF(II)250 binds to TBP and represses its interaction with TATA boxes, thereby decreasing DNA binding by TFIID. We hypothesized that c-Jun is capable of derepressing the effect of the TAF(II)250 N terminus on TFIID-driven transcription. In support of this hypothesis, we found that c-Jun increased levels of TFIID-driven transcription in vitro when added at high concentrations to a DNA template lacking activator protein 1 (AP-1) sites. Moreover, c-Jun blocked the repression of TBP DNA binding caused by the N terminus of TAF(II)250. In addition to revealing a mechanism by which c-Jun activates transcription, our studies provide the first evidence that an activator can bind directly to the N terminus of TAF(II)250 to derepress RNA polymerase II transcription in vitro.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11316804     DOI: 10.1074/jbc.M100278200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Expression and purification of recombinant human c-Fos/c-Jun that is highly active in DNA binding and transcriptional activation in vitro.

Authors:  H A Ferguson; J A Goodrich
Journal:  Nucleic Acids Res       Date:  2001-10-15       Impact factor: 16.971

Review 2.  Emerging roles of ATF2 and the dynamic AP1 network in cancer.

Authors:  Pablo Lopez-Bergami; Eric Lau; Ze'ev Ronai
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

3.  p53 Dynamically Directs TFIID Assembly on Target Gene Promoters.

Authors:  R A Coleman; Z Qiao; S K Singh; C S Peng; M Cianfrocco; Z Zhang; A Piasecka; H Aldeborgh; G Basishvili; W L Liu
Journal:  Mol Cell Biol       Date:  2017-06-15       Impact factor: 4.272

Review 4.  Dampening DNA binding: a common mechanism of transcriptional repression for both ncRNAs and protein domains.

Authors:  James A Goodrich; Jennifer F Kugel
Journal:  RNA Biol       Date:  2010-05-26       Impact factor: 4.652

5.  Dual Inhibition of TAF1 and BET Bromodomains from the BI-2536 Kinase Inhibitor Scaffold.

Authors:  David Remillard; Dennis L Buckley; Hyuk-Soo Seo; Fleur M Ferguson; Sirano Dhe-Paganon; James E Bradner; Nathanael S Gray
Journal:  ACS Med Chem Lett       Date:  2019-09-13       Impact factor: 4.345

6.  TAF1 differentially enhances androgen receptor transcriptional activity via its N-terminal kinase and ubiquitin-activating and -conjugating domains.

Authors:  Peyman Tavassoli; Latif A Wafa; Helen Cheng; Amina Zoubeidi; Ladan Fazli; Martin Gleave; Robert Snoek; Paul S Rennie
Journal:  Mol Endocrinol       Date:  2010-02-24

7.  Interactions between c-Jun, nuclear factor 1, and JC virus promoter sequences: implications for viral tropism.

Authors:  Veerasamy Ravichandran; Bruce F Sabath; Peter N Jensen; Sidney A Houff; Eugene O Major
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

8.  Mutations in the histone fold domain of the TAF12 gene show synthetic lethality with the TAF1 gene lacking the TAF N-terminal domain (TAND) by different mechanisms from those in the SPT15 gene encoding the TATA box-binding protein (TBP).

Authors:  Akiko Kobayashi; Tsuyoshi Miyake; Masashi Kawaichi; Tetsuro Kokubo
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

9.  Autonomous function of the amino-terminal inhibitory domain of TAF1 in transcriptional regulation.

Authors:  Shinya Takahata; Koji Kasahara; Masashi Kawaichi; Tetsuro Kokubo
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

10.  Relationship between interleukin-1 type 1 and 2 receptor gene polymorphisms and the expression level of membrane-bound receptors.

Authors:  F F Vasilyev; A N Silkov; S V Sennikov
Journal:  Cell Mol Immunol       Date:  2014-06-30       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.